Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome
Open Access
- 9 January 2010
- journal article
- case report
- Published by Springer Science and Business Media LLC in The Journal of Headache and Pain
- Vol. 11 (2), 167-169
- https://doi.org/10.1007/s10194-009-0182-7
Abstract
A pregnant young woman with a severe migraine is prescribed candesartan, an angiotensin II type 1 receptor antagonist (AT II antagonists). This has a positive effect—except for severe maldevelopment of her fetus. There is an increase in the use of the fetotoxic drugs, AT II antagonists and angiotensin-converting enzyme inhibitors, as prophylactic treatment of migraines, in addition to their use as hypertensives.Keywords
This publication has 15 references indexed in Scilit:
- Migraine prophylaxis.2008
- Inhibition of Angiotensin II receptors during pregnancy induces malformations in developing rat kidneyEuropean Journal of Pharmacology, 2008
- Oligohydramnios and pulmonary hypoplasia: A case in which involvement of an angiotensin II receptor antagonist was suspectedJournal of Obstetrics and Gynaecology Research, 2008
- Current Trends in Migraine ProphylaxisHeadache: The Journal of Head and Face Pain, 2007
- Renal Tubular Dysgenesis, a Not Uncommon Autosomal Recessive Disorder Leading to OligohydramniosJournal of the American Society of Nephrology, 2006
- EFNS guideline on the drug treatment of migraine – report of an EFNS task forceEuropean Journal of Neurology, 2006
- Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 casesBJOG: An International Journal of Obstetrics and Gynaecology, 2005
- Prophylactic Treatment of Migraine With an Angiotensin II ReceptorBlockerJAMA, 2003
- Efficacy of angiotensin II receptor antagonists in preventing headache: a systematic overview and meta-analysisAmerican Journal Of Medicine, 2002
- ACE Inhibitors for Prophylaxis of Migraine HeadachesHeadache: The Journal of Head and Face Pain, 1995